Amyloid transthyretin cardiomyopathy (ATTR-CM) is a progressive and life-threatening heart disease that can lead to increased ventricular wall thickness, restrictive cardiomyopathy, and heart failure.

The administration of ARGX-119 led to improved survival and muscle function in a passive transfer myasthenia gravis (MG) mice model, a study found.

New research shows the KIT p.D816V mutation is a significant predictor of adverse events during honeybee VIT and can predict VIT failure after wasp VIT.

Are you a healthcare provider looking for information on Diffuse Large B-Cell Lymphoma Epidemiology? Read about it here.

The relative apical sparing index (RASI) appears to accurately distinguish patients with AL-CM from those with ATTR-CM, a study found.

A new study found that a 4-week donidalorsen dosing regimen was superior to 8-week dosing in patients with hereditary angioedema (HAE).

The addition of a 4-biomarker panel to morphology significantly aids the classification of intrahepatic cholangiocarcinoma (iCCA) specimens.

Elafibranor seems to be slightly more effective than seladelpar as a second-line therapy in obtaining a biochemical response in patients with primary biliary cholnagitis (PBC), according to a systemic ...

Researchers presented the case of a patient with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) coexisting with RA.

Researchers have proposed a link between the availability of maternal-fetal medicine (MFM) physicians and decreased rates of maternal mortality.

A significant proportion of patients with B-cell ALL require third-line treatment, despite limited effective options.

Columnist with immune thrombocytopenia (ITP) gives tips for those recently diagnosed with the condition, including research and journaling.